(S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one CAS 2222964-03-4
| CAS No. | 2222964-03-4 |
| Molecular Formula | C25H26BrF2N3O2 |
| Molecular Weight | 518.39 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of (S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one is closely related to a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine/bromine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies (S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one (CAS 2222964-03-4), a certified reference material (molecular formula C25H26BrF2N3O2, MW 518.39 g/mol) for analytical method development and quality control.
The molecular framework of (S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one (C25H26BrF2N3O2) is characterized by a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine/bromine substitution. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures (S)-6-(5-Bromo-1-((1r,4S)-4-methoxycyclohexyl)-1H-benzo[d]imidazol-2-yl)-1-(3,4-difluorophenyl)piperidin-2-one under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C25H26BrF2N3O2 |
| Molecular Weight | 518.39 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 13.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1998 |
| Halogen Content | F/Br-containing |
| Nitrogen Atoms | 3 |
Related S Standards
- 1-((5-Bromo-2-(trifluoromethoxy)phenyl)sulfonyl)-4-((tert-butyldimethylsilyl)oxy)piperidine (CAS 1704065-48-4)
- 9-Bromo-5-(4-bromophenyl)-2-(4-chlorophenyl)-5,10b-dihydro-1H-benzo[e]pyrazolo[1,5-c][1,3]oxazine (CAS 332060-73-8)
- (2E)-3-(6-Bromo-2H-1,3-benzodioxol-5-yl)-1-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}prop-2-en-1-one (CAS 478078-34-1)
- 9-Bromo-2-(4-bromophenyl)-1'-propyl-1,10b-dihydrospiro[benzo[e]pyrazolo[1,5-c][1,3]oxazine-5,4'-piperidine] (CAS 303094-70-4)
- 9-Bromo-5,6-dihydro-2,3-diiodo-imidazo[1,2-d][1,4]benzoxazepine (CAS 1282516-68-0)
- 6-Bromo-3-(2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)-1-(phenylsulfonyl)-1H-indole (CAS 2173193-44-5)
- N-(2-Bromo-4,6-difluorophenyl)-2-((5-(pyridin-4-yl)-4-(p-tolyl)-4H-1,2,4-triazol-3-yl)thio)acetamide (CAS 477318-66-4)
- 3-Bromo-2,5-difluoro-N,N-bis(4-methoxybenzyl)-4-(trifluoromethyl)aniline (CAS 2852766-96-0)
Recommended Standards
- 9,10[1',2']-Benzenoanthracene-2,3,6,7,14,15-hexacarboxylicacid,9,10-dihydro (CAS 945681-56-1)
- Ketoconazole impurity 27 (CAS CATO-C4X-147227)
- 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[[hydroxy-[hydroxy(imidazol-1-yl)phosphoryl]oxy-phosphoryl]oxymethyl]tetrahydrofuran-2-yl]-7-methyl-purin-7-ium-6-olate (CAS 531553-69-2)
- Avanafil Impurity 118 (CAS CATO-C4X-1118118)
- 2-(Benzyloxy)cyclobutan-1-amine (CAS 1824515-71-0)
- Tretazicar (CAS 21919-05-1)
- 2-(1-(Benzylamino)cyclobutyl)ethan-1-ol (CAS 1132814-48-2)
- 3-(4-Chlorothieno[2,3-d]pyrimidin-2-yl)pyridine (CAS 1188085-59-7)
- 3-Chloro-6-[(2-chlorophenyl)methyl]pyridazine (CAS 339008-53-6)
- 3-(3-Fluorophenyl)propan-1-amine hydrochloride (CAS 104774-91-6)
- 3-Aminopyrazole-4-carboxylic acid (CAS 41680-34-6)
- 5-Fluoro-4-formyl-3-methoxyphenylboronic acid (CAS 2633633-50-6)
- 3-[2-(3,4-Difluorophenoxy)ethyl]piperidinehydrochloride (CAS 1220016-90-9)
- FMRF-Like Peptide from snail Helix aspersa (CAS 98495-35-3)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com